1998
DOI: 10.1002/(sici)1097-0142(19981025)84:5<273::aid-cncr2>3.3.co;2-r
|View full text |Cite
|
Sign up to set email alerts
|

Performance of a semiautomated papanicolaou smear screening system

Abstract: In this study, PAPNET-assisted cytologic screening accurately identified smears obtained from women with high grade SIL or carcinoma. Determination of the clinical cost-effectiveness of PAPNET-assisted screening in routine practice awaits future study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…using the PAPNET (NSI, Suffern, NY) system, a semiautomated, computerassisted screening device. 22 The Thin-Prep slide was stained using a modified HPV TESTING IN CERVICAL CANCER Pap method and screened, then interpreted by a cytopathologist expert in ThinPrep cytology (M.H.). The 3 cytologic diagnoses (conventional, PAPNETassisted, and ThinPrep) were made as per the Bethesda system as within normal limits or reactive cellular changes (negative), atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion, high-grade squamous intraepithelial lesion, or carcinoma.…”
Section: Clinical Evaluationmentioning
confidence: 99%
See 1 more Smart Citation
“…using the PAPNET (NSI, Suffern, NY) system, a semiautomated, computerassisted screening device. 22 The Thin-Prep slide was stained using a modified HPV TESTING IN CERVICAL CANCER Pap method and screened, then interpreted by a cytopathologist expert in ThinPrep cytology (M.H.). The 3 cytologic diagnoses (conventional, PAPNETassisted, and ThinPrep) were made as per the Bethesda system as within normal limits or reactive cellular changes (negative), atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion, high-grade squamous intraepithelial lesion, or carcinoma.…”
Section: Clinical Evaluationmentioning
confidence: 99%
“…Cytology will likely continue to be the major screening method for cervical cancer prevention in the United States, but it has proven difficult to standardize at the highest levels of expertise. We are actively working on novel cervical cancer diagnostic assays in Costa Rica [20][21][22] and in US centers participating in an HPV testing study of management of low-grade and equivocal cytologic abnormalities. 27 In the US trial, we have seen that HPV assays such as HC II can be optimized and performed routinely at regional laboratories.…”
Section: Commentmentioning
confidence: 99%
“…A. ); PapNet 4 (Neuromedical Systems, Inc, Suffern, NY [now TriPath, Elon, NC]), which uses the same slide as the Papanicolaou smear (M. E. S.); and ThinPrep 3 (M. L. H.). The Papanicolaou smear, ThinPrep, and PapNet results were classified according to the Bethesda system as negative, atypical squamous cells of undetermined significance, low-grade squamous intraepithelial lesion, high-grade squamous intraepithelial lesion, or carcinoma.…”
Section: Methodsmentioning
confidence: 99%
“…The Guanacaste site was selected because of its consistently high age-adjusted rates of cervical cancer, despite existing Papanicolaou smear screening services. 1 Visual, 2 microscopic, 3,4 and molecular 5 screening techniques are under study.…”
mentioning
confidence: 99%
“…Such programmes have been introduced into comprehensive training and QC programmes in the USA and in the UK NHS CSP. Automated prescreening and rescreening using image analysis also may assist in standardisation [49].…”
Section: Improving Cytological Reproducibility and Accuracymentioning
confidence: 99%